Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01607229 · ClinicalTrials.gov registry record
Multi-frequency Bioelectrical Impedance for Estimating Total Body Water by Deuterium Dilution
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 25
- Enrollment target
NCT01607229 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 25 participants.
The verdict
NCT01607229 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
SPECIFIC AIM: Determine the validity of the Biospace bioelectrical impedance devices compared to deuterium water (D2O) measurements. HYPOTHESIS: The Biospace Body Composition Analyzers are valid tools for measuring total body water and body composition.
Interventions
- OTHER observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01607229
The ClinicalTrials.gov registry entry for NCT01607229 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which observation is the first listed.
NCT01607229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01607229 about?
NCT01607229 is a clinical study titled "Multi-frequency Bioelectrical Impedance for Estimating Total Body Water by Deuterium Dilution". SPECIFIC AIM: Determine the validity of the Biospace bioelectrical impedance devices compared to deuterium water (D2O) measurements. HYPOTHESIS: The Biospace Body Composition Analyzers are valid tools for measuring total body water and body composition.
What is the current status of trial NCT01607229?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2010-01. Estimated completion is 2010-05.
What interventions are being tested in trial NCT01607229?
The interventions under investigation include: observation (OTHER).
Who is sponsoring clinical trial NCT01607229?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.